(Q40383866)

English

Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial

scientific article published on 25 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

hemodialysis patient

1 reference

based on heuristic

inferred from title

Maria Rosaria Capobianchi

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Maria Rapicetta

7

object named as

Maria Rapicetta

0 references

object named as

Paola Rizza

5

0 references

object named as

Marina Selleri

10

0 references

Filippo Belardelli

object named as

Filippo Belardelli

12

0 references

Concetta Castilletti

11

object named as

Concetta Castilletti

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

María E Miquilena-Colina

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Tamara Lozano-Rodríguez

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Leonor García-Pozo

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Alicia Sáez

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Imerio Capone

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Paola Chionne

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Oreste Lo Iacono

13

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Carmelo García-Monzón

14

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

25 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5654-5660

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hepatitis B virus infection--natural history and clinical consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Status of hepatitis B immunization programmes in 1998

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Global control of hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Active hepatitis B vaccination of dialysis patients and medical staff

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Disturbances of acquired immunity in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Chronic viral hepatitis in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Cytokines as natural adjuvants for vaccines: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

A New Type I IFN-Mediated Pathway for the Rapid Differentiation of Monocytes into Highly Active Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Exploring the native human antibody repertoire to create antiviral therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Study of IgG subclass profiles of anti-HBs in populations with different HBV infection status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

The essential role of chemokines in the selective regulation of lymphocyte homing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Outcome of liver transplantation for hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.014

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.07.014

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40383866&oldid=2165326415"